Ginkgo bioworks holdings, inc.DNA.US Overview

US StockHealthcare

(No presentation for DNA)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

DNA Overall Performance

DNA AI Analysis & Strategy

DNA Recent Performance

-1.66%

Ginkgo bioworks holdings, inc.

0.81%

Avg of Sector

-1.14%

S&P500

DNA PowerScanner

DNA Key Information

DNA Valuation Metrics

DNA Earnings Table

DNA Profile

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.